Amgen Financial Statements From 2010 to 2026

Amgen Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 95.1 B 90.6 B 68.1 B Slightly volatile Short and Long Term Debt Total 57.3 B 54.6 B 36.3 B Slightly volatile Other Current Liabilities 21.3 B 20.3 B 9.3 B Slightly volatile Total Current Liabilities 26.8 B 25.5 B 12.8 B Slightly volatile Total Stockholder Equity 11.8 B 8.7 B 14.3 B Slightly volatile Property Plant And Equipment Net 8.3 B 7.9 B 5.3 B Slightly volatile Cash 9.6 B 9.1 B 6.2 B Slightly volatile Non Current Assets Total 64.6 B 61.5 B 39.1 B Slightly volatile Non Currrent Assets Other 13.3 B 12.7 B 4.6 B Slightly volatile Cash And Short Term Investments 10.3 B 9.1 B 18.3 B Slightly volatile Net Receivables 10 B 9.6 B 4.7 B Slightly volatile Common Stock Shares Outstanding 726.4 M 542 M 670.3 M Slightly volatile Liabilities And Stockholders Equity 95.1 B 90.6 B 68.1 B Slightly volatile Non Current Liabilities Total 59.3 B 56.4 B 41.1 B Slightly volatile Other Current Assets 4.3 B 4.1 B 2.1 B Slightly volatile Total Liabilities 86 B 81.9 B 53.9 B Slightly volatile Property Plant And Equipment Gross 20.4 B 19.5 B 9 B Slightly volatile Total Current Assets 16 B 29.1 B 28.1 B Very volatile Short Term Debt 4.8 B 4.6 B 2.2 B Slightly volatile Inventory 6.5 B 6.2 B 4 B Slightly volatile Accounts Payable 21.9 B 20.9 B 3.5 B Slightly volatile Common Stock Total Equity 27.1 B 37.4 B 29.4 B Slightly volatile Short Term Investments 12.2 B 12.6 B 14.9 B Slightly volatile Capital Stock 27.8 B 38.6 B 29.7 B Slightly volatile Common Stock 8.2 B 8.7 B 26.7 B Very volatile Other Assets 1.4 B 2.5 B 1.9 B Pretty Stable Long Term Debt 68.3 B 65 B 36 B Slightly volatile Property Plant Equipment 5.3 B 6.2 B 5 B Slightly volatile Good Will 14.9 B 18.7 B 14.9 B Slightly volatile Intangible Assets 13.7 B 22.3 B 14.6 B Slightly volatile Other Liabilities 5.1 B 9.1 B 6.5 B Slightly volatile Long Term Debt Total 29.9 B 43 B 30.4 B Slightly volatile Non Current Liabilities Other 5.2 B 2.7 B 4.8 B Very volatile Long Term Investments 810.9 M 918.9 M 719.7 M Slightly volatile Short and Long Term Debt 1.6 B 3.2 B 1.7 B Slightly volatile Net Invested Capital 54.7 B 75.9 B 56 B Very volatile Net Working Capital 5.1 B 5.3 B 23.8 B Slightly volatile
Amgen Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 5.6 B 5.4 B 2.8 B Slightly volatile Interest Expense 2.9 B 2.8 B 1.5 B Slightly volatile Selling General Administrative 2.7 B 2.7 B 4 B Very volatile Total Revenue 38.6 B 36.8 B 23.6 B Slightly volatile Gross Profit 31.8 B 30.3 B 18.4 B Slightly volatile Other Operating Expenses 23 B 21.9 B 15.2 B Slightly volatile EBITDA 18 B 17.1 B 10.8 B Slightly volatile Total Operating Expenses 16.2 B 15.4 B 10 B Slightly volatile Income Before Tax 9.4 B 9 B 7 B Slightly volatile Net Income 8.1 B 7.7 B 5.7 B Slightly volatile Income Tax Expense 837.1 M 1.3 B 1.2 B Very volatile Research Development 7.6 B 7.3 B 4.4 B Slightly volatile Net Income Applicable To Common Shares 5 B 7.5 B 5.7 B Slightly volatile Net Income From Continuing Ops 6.3 B 4.7 B 5.8 B Slightly volatile Tax Provision 443.7 M 467.1 M 1.3 B Pretty Stable Interest Income 218.9 M 230.4 M 450.9 M Slightly volatile Selling And Marketing Expenses 5.7 B 5.4 B 1.4 B Slightly volatile Reconciled Depreciation 3.5 B 6.4 B 2.9 B Slightly volatile Non Recurring 1.2 B 1.4 B 1.5 B Slightly volatile
Amgen Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Begin Period Cash Flow 12.6 B 12 B 6 B Slightly volatile Depreciation 6.8 B 6.4 B 2.9 B Slightly volatile Capital Expenditures 2 B 1.9 B 878.9 M Slightly volatile End Period Cash Flow 9.6 B 9.1 B 6.2 B Slightly volatile Dividends Paid 3 B 5.6 B 3.1 B Slightly volatile Change To Operating Activities 637.1 M 1.2 B 711.3 M Pretty Stable
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 8.8 4.7915 5.6104 Very volatile Dividend Yield 0.0194 0.0291 0.023 Slightly volatile PTB Ratio 21.36 20.3387 12.8728 Slightly volatile Days Sales Outstanding 48.57 95.0464 64.7001 Slightly volatile Book Value Per Share 10.3 16.0929 19.9512 Slightly volatile Stock Based Compensation To Revenue 0.0185 0.0182 0.0166 Slightly volatile Capex To Depreciation 0.21 0.23 0.6413 Slightly volatile PB Ratio 21.36 20.3387 12.8728 Slightly volatile EV To Sales 9.27 6.0289 6.6006 Slightly volatile Inventory Turnover 0.98 1.0318 3.3419 Slightly volatile Net Income Per Share 15.05 14.3327 9.1457 Slightly volatile Days Of Inventory On Hand 220 354 263 Pretty Stable Payables Turnover 0.29 0.3075 3.832 Slightly volatile Research And Ddevelopement To Revenue 0.22 0.1979 0.1894 Pretty Stable Capex To Revenue 0.048 0.0506 0.0703 Slightly volatile Cash Per Share 10.18 16.9684 26.0609 Pretty Stable Interest Coverage 7.39 5.4051 6.4502 Slightly volatile Payout Ratio 0.46 0.6642 0.5463 Slightly volatile Days Payables Outstanding 1.2 K 1.2 K 221 Slightly volatile Income Quality 1.13 1.2914 1.6565 Very volatile ROE 0.94 0.8906 0.5864 Slightly volatile PE Ratio 21.69 22.8366 47.832 Slightly volatile Return On Tangible Assets 0.12 0.1554 0.1437 Slightly volatile Earnings Yield 0.0302 0.0438 0.0463 Pretty Stable Intangibles To Total Assets 0.48 0.4521 0.4325 Slightly volatile Current Ratio 1.08 1.14 3.5331 Slightly volatile Receivables Turnover 7.33 3.8402 6.0274 Slightly volatile Graham Number 75.64 72.0399 60.0111 Pretty Stable Shareholders Equity Per Share 10.29 16.0929 19.9408 Slightly volatile Debt To Equity 6.62 6.3068 3.9643 Slightly volatile Capex Per Share 3.63 3.4535 1.4318 Slightly volatile Revenue Per Share 71.73 68.3104 38.1343 Slightly volatile Interest Debt Per Share 112 107 61.6141 Slightly volatile Debt To Assets 0.63 0.6028 0.5006 Slightly volatile Enterprise Value Over EBITDA 12.29 12.9322 18.6519 Slightly volatile Price Earnings Ratio 21.69 22.8366 47.832 Slightly volatile Operating Cycle 257 449 326 Slightly volatile Price Book Value Ratio 21.36 20.3387 12.8728 Slightly volatile Days Of Payables Outstanding 1.2 K 1.2 K 221 Slightly volatile Dividend Payout Ratio 0.46 0.6642 0.5463 Slightly volatile Pretax Profit Margin 0.24 0.2442 0.2872 Very volatile Effective Tax Rate 0.22 0.1409 0.1659 Very volatile Company Equity Multiplier 10.99 10.4627 6.9603 Slightly volatile Long Term Debt To Capitalization 0.9 0.8524 0.6711 Slightly volatile Total Debt To Capitalization 0.91 0.8631 0.6825 Slightly volatile Debt Equity Ratio 6.62 6.3068 3.9643 Slightly volatile Quick Ratio 0.85 0.8958 3.2307 Slightly volatile Net Income Per E B T 0.64 0.8591 0.8258 Pretty Stable Cash Ratio 0.34 0.3582 1.3207 Slightly volatile Days Of Inventory Outstanding 220 354 263 Pretty Stable Days Of Sales Outstanding 48.57 95.0464 64.7001 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 0.64 0.8134 1.3235 Slightly volatile Price To Book Ratio 21.36 20.3387 12.8728 Slightly volatile Fixed Asset Turnover 2.36 4.6444 4.1191 Slightly volatile Enterprise Value Multiple 12.29 12.9322 18.6519 Slightly volatile Debt Ratio 0.63 0.6028 0.5006 Slightly volatile Price Sales Ratio 8.8 4.7915 5.6104 Very volatile Return On Assets 0.12 0.0851 0.0837 Slightly volatile Asset Turnover 0.5 0.4057 0.3448 Slightly volatile Net Profit Margin 0.18 0.2098 0.2344 Very volatile Gross Profit Margin 0.64 0.8252 0.7958 Slightly volatile Price Fair Value 21.36 20.3387 12.8728 Slightly volatile Return On Equity 0.94 0.8906 0.5864 Slightly volatile
Amgen Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 121.6 B 115.8 B 114.5 B Slightly volatile Enterprise Value 53.9 B 51.4 B 53.2 B Slightly volatile

Amgen Fundamental Market Drivers

Amgen Upcoming Events

About Amgen Financial Statements

Pair Trading with Amgen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will appreciate offsetting losses from the drop in the long position's value.When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:

How To Invest In Amgen Details

Is Amgen Stock a good investment? Details

What is Amgen's Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details